The United States may be on the verge of becoming a net exporter of energy products. Ultimately along with the rebirth of the housing sector, this could be the engine ... Read Full Story »
We have reported at great length recently on the lists put out by Wall Street firms that highlight their best of the best picks. Whether it is the “Conviction Buy List,” ... Read Full Story »
At a meeting in New York this morning, Exxon Mobil Corp. (NYSE: XOM) CEO Rex Tillerson said that his company is “losing our shirts” on natural gas production. Did he ... Read Full Story »
It has been almost exactly two years since Exxon Mobil Corp. (NYSE: XOM) completed its $31 billion merger with XTO Energy to create the largest natural gas company in the ... Read Full Story »
These are some of Tuesday's top analyst upgrades, downgrades, and initiations seen from Wall Street research calls. Alcatel-Lucent SA (NYSE: ALU) Cut to Neutral at JPMorgan. ARM Holdings PLC (NASDAQ: ... Read Full Story »
A barrel of oil contains about six times as much energy as a thousand cubic feet of natural gas. By that metric, at today's WTI price of around $90/barrel, natural ... Read Full Story »
If you believe that an energy policy in the United States can happen in the coming years, there is almost no way that natural gas can be ignored. The massive ... Read Full Story »
Restructuring never ends in many large corporations. After a week's worth of reading through dozens of corporate deals in the pipeline and analyzing others which could be close, it seems ... Read Full Story »
Chinese Solar stocks, as measured by Tickerspy's Chinese Solar Stocks Index (*CHSOL), are up over 4.5% today. The solar sector has performed poorly in recent weeks as a policy shift ... Read Full Story »
This morning we got to see the new equity holdings of T. Boone Pickens, via his BP Capital Management, L.P., as of March 31, 2009. Some of the higher stakes ... Read Full Story »
These are some of the top pre-market upgrades and downgrades we have seen from Wall Street analysts this Monday morning:Devon Energy (DVN) Raised to Buy at Jefferies.EnCana (ECA) Raised to ... Read Full Story »
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering integration.(BMY) Bristol-Myers: ... Read Full Story »